Koelis, SAS ("Koelis" or the "Company", a leader and innovator in MRI-ultrasound fusion guidance for prostate cancer interventions, recently announced that the Centers for Medicare & Medicaid ...

Anyone discouraged by the continued absence of a prostate cancer screening programme, the difficulties in getting a clear ...

NovaUCD-based medtech OncoAssure has signed a research collaboration agreement with the Icahn School of Medicine at Mount ...

Prostate cancer has overtaken breast cancer to become the most common form of the disease in the UK for the first time.

“For localised prostate cancer, treatment options include surgery or radiotherapy. Both give equivalent cure rates,” Dr Komen ...

St Vincent’s is only the second hospital in Australia to operate the Da Vinci Single Port system, following a site in ...

The patient told police that Muscoreil "became angry and raised his voice at her" after she expressed concerns about the ...

The disease was projected to account for 30 per cent of all new cancers among men nationwide. Cancer diagnoses among younger ...

Cribriform-negative disease had a low metastasis rate unaffected by treatment. After radiation therapy with neoadjuvant ADT group, men with cribriform-positive disease had the same metastasis rate as ...

State Sen. Don DeWitte announced Monday that he is being treated for prostate cancer but expects to be back at work in the state Capitol next month. DeWitte, a St. Charles Republican who represents ...

New data from the American Cancer Society shows major progress in cancer survival, with nearly 70% of people now living at ...

Separately, Irish medtech company OncoAssure signs collaboration with New York medical school to test prostate cancer product ...